1.What does Charles River Laboratories do?
Charles River Laboratories is a full service, early-stage contract research organization (CRO). The company has built upon its core competency of laboratory animal medicine and science (research model technologies) to develop a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP, which is able to support its clients from target identification through non-clinical development. Charles River also provides a suite of products and services to support clients’ manufacturing activities. Utilizing the company’s broad portfolio of products and services enables clients to create a more flexible drug development model, which reduces their costs, enhances their productivity and effectiveness, and increases speed to market.
2.When was the company founded?
Charles River Laboratories was founded in 1947.
3.Where is the company headquartered?
The company’s corporate offices are located at 251 Ballardvale Street, Wilmington, Massachusetts, USA.
4.When did Charles River Laboratories become a publicly traded company?
Charles River initially went public in 1968 on the NASDAQ and was later bought by Bausch & Lomb in 1984. In September 1999, the executive management team completed a leveraged buyout of the company. In June 2000, the company launched an initial public offering and again became a public company. It trades on the New York Stock Exchange under the ticker symbol “CRL.”
5.Does Charles River have operations outside the United States?
CRL is a global company with operations in the United States, Canada, United Kingdom, Europe, Japan and China.
6.How many people does Charles River Laboratories employ?
Approximately more than 17,000 employees worldwide.
7.Who are Charles River Laboratories’ directors and executive officers?
8.Who are the independent auditors for Charles River Laboratories?
9.Who is Charles River’s Stock Transfer Agent and Registrar?
10.How can I receive information about Charles River Laboratories?